US3420233A - Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region - Google Patents

Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region Download PDF

Info

Publication number
US3420233A
US3420233A US510161A US3420233DA US3420233A US 3420233 A US3420233 A US 3420233A US 510161 A US510161 A US 510161A US 3420233D A US3420233D A US 3420233DA US 3420233 A US3420233 A US 3420233A
Authority
US
United States
Prior art keywords
ulcers
epithelialization
gold leaf
ulcer
granulation tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US510161A
Inventor
Naomi M Kanof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAOMI M KANOF
Original Assignee
NAOMI M KANOF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAOMI M KANOF filed Critical NAOMI M KANOF
Application granted granted Critical
Publication of US3420233A publication Critical patent/US3420233A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Definitions

  • ABSTRACT OF THE DISCLOSURE A method of treating a cutaneous ulcer by the application of porous gold leaf, establishing an electrostatic difierential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying the porous gold leaf thereto.
  • This invention relates to the treatment of ischemic ion-healing ulcers of the skin by the application of gold leaf.
  • the Gold leaf as used herein, means 23K XX Deep Gold Leaf for Glass, which is a standard designation for the partcular type of gold leaf used in this method and which type, supplied by the Hastings Company, of Philadelphia, Pcnnslyvania, can be obtained at artist supply stores. Its thickness is about 0.0000036 inch.
  • This gold leaf is characterized by low content of base metal, a certain porosity, a thickness to permit easy handling and manual application over a skin ulcer so that it closely conforms to virtually all the minute and varied contours of the ulcer and the immediate surrounding area. Substantially thinner gold leaf is difficult to handle because it tends to adhere to the interleaving paper tissues with which it is packaged. Substantially thicker gold leaf does not accommodate to the irregular surface of an ulcer and tends to be too occlusive.
  • the gold leaf remained in situ except in the case of one incontinent Woman with a decubitus ulcer of the buttock (the washing away of the gold by urine every nite necessitate daily reapplication), The sites Were observed and the gold leaf was re-applied at two day intervals.
  • the patients were random, constituting all the available patients with non-healing ulcers at the institution in which the study was performed. A compilation of the study is as follows:
  • Non-healing cutaneous ulcers means those which do not respond to usual active therapy.
  • Usual active therapy means topical applications of antibiotic and proteolytic agents (including aloe vera).
  • Granulation as used herein, means tissue which includes blood vessels.
  • the application of gold leaf on to ulcers results in stimulation of vascular activity and the production of granulation tissue.
  • the porosity of the gold leaf permits some evaporation of the moisture beneath it, it having been observed that if the leaf is covered by an occlusive substance or dressing, there is interference with healing.
  • the gold leaf can be applied Without initially swabbing of the site, it is preferred that the site first be swabbed with ethyl alcohol, not only to cleanse it, but also to establish the electrostatic differential which causes the leaf to adhere closely to the irregular surface of the ulcer with little or no further manipulation required.
  • the invention embraces a therapeutic device, i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin.
  • a therapeutic device i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin.
  • the invention is not limited to the specific method or article, but is intended to cover all substitutions, modifications, and equivalents within the scope of the following claim.
  • the method of stimulating epithelialization in a cutaneous region at and proximate to an avascular ulcer other than a cutaneous region fed by blood containing sickle cells by means of sterile porous gold leaf applied thereto which comprises, first establishing an electrostatic differential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying said sterile porous golf leaf in intimate engagement over said ulcer and the cutaneous surface immediately contiguous thereto, and maintaining said gold leaf so applied until epithelialization is stimulated and develops at the ulcer.

Description

United States Patent Ofifice 3,420,233 Patented Jan. 7, 1969 3,420,233 METHOD AND THERAPEUTIC DEVICE FOR STIMULATING VASCULAR ACTIVITY, PRO- DUCTION F GRANULATION TISSUE, AND EPITHELIALIZATION IN A CUTANEOUS REGION Naomi M. Kanof, 2120 Bancroft Place NW., Washington, D.C. 20008 No Drawing. Filed Nov. 24, 1965, Ser. No. 510,161 US. Cl. 128-260 1 Claim Int. Cl. A61m 35/00 ABSTRACT OF THE DISCLOSURE A method of treating a cutaneous ulcer by the application of porous gold leaf, establishing an electrostatic difierential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying the porous gold leaf thereto.
This invention relates to the treatment of ischemic ion-healing ulcers of the skin by the application of gold leaf.
In previous reports (Gallager, I. P., and Geschickter, C. F.: The Use of Charged Gold Leaf in Surgery, JAMA, 189:928, 1964, and Editorial Comment, JAMA, 189:944, 1964) investigations into the use of gold leaf in patching the dura mater was disclosed. The subject arose out of observations of the combination of the metals characteristics of adhesion and to the extreme pliability to minute topographic variations of body tissues, plus its well-known absence of allergic sensitization, of irradiation, and of oxidation. Pilot experiments in which 68 non-healing electrodesiccated cutaneous ulcer sites were dressed with electrostatic gold leaf tended to confirm the original hypothesis that, by the application of gold leaf over cutaneous ulcers, early restitution of tissue could be seen to be taking place. Clinically, it soon became apparent that the Gold leaf, as used herein, means 23K XX Deep Gold Leaf for Glass, which is a standard designation for the partcular type of gold leaf used in this method and which type, supplied by the Hastings Company, of Philadelphia, Pcnnslyvania, can be obtained at artist supply stores. Its thickness is about 0.0000036 inch. This gold leaf is characterized by low content of base metal, a certain porosity, a thickness to permit easy handling and manual application over a skin ulcer so that it closely conforms to virtually all the minute and varied contours of the ulcer and the immediate surrounding area. Substantially thinner gold leaf is difficult to handle because it tends to adhere to the interleaving paper tissues with which it is packaged. Substantially thicker gold leaf does not accommodate to the irregular surface of an ulcer and tends to be too occlusive.
In one controlled experiment, six patients with eleven long-standing non-healing skin ulcers from one to two inches in diameter and unresponsive to usual active therapy were treated with the application of four to eight layers of autoclaved gold leaf (23K XX Deep Gold Leaf for Glass, as aforesaid, and obtained from an artist supply store) after the sites were cleansed with ethyl alcohol. The swabbing of the sites with ethyl alcohol apparently resulted in an increase in electrostatic differential so that the leaf was attracted to the surfaces of the ulcers without the need for stroking with a brush. The sterilized leaf was applied over each ulcer and over the contiguous cutaneous surface. The sites were left uncovered: no other dressing or treatment was used for the duration of the study. The gold leaf remained in situ except in the case of one incontinent Woman with a decubitus ulcer of the buttock (the washing away of the gold by urine every nite necessitate daily reapplication), The sites Were observed and the gold leaf was re-applied at two day intervals. The patients were random, constituting all the available patients with non-healing ulcers at the institution in which the study was performed. A compilation of the study is as follows:
TABLE Patient Size and duration Clinical data Response to gold. leaf 0 ulcers (1) RS Wt 83 yrs 2 ulcers, largest one 2 in. Thrombosis with cellulitis, Pus formation markedly rein diam. 1 month pus, maggots, dissecting duced in 24 hrs; lesions duration. border. dry, epithelialization at (2) ML wt 74 yrs 3 ulcers, each one in. in
diam. 3 month duration.
(3) RE wt 85 yrs Ulcer of dors. of large toe.
3 month duration.
(4) AM wt 67 yrs 2 ulcers, one in. in diam.
6 month duration.
(5) FF Wm 57 yrs 2 ulcers, over one in. in
diam. 5 month duration.
(6) FF wt 73 yrs 1% in.
duratlon.
ulcer over 1 wk Dry crust in 4 days; healing complete in 6 days.
Diabetic; left leg ampu- Smaller ulcer healed in 6 tated; ulcers oi rt. heel. days; larger dry but not completely epitheliized in 10 days. Diabetic; rt. leg ampu- Lesion of 2nd toe not tated; ulcers of 2nd and healed but very vascular;
4th left toes. 4th toe healed in 4 days.
Advanced Parkinsonism; Lesions dry; epithelializagerigbiflus ulcer of rt. tion noted in two days.
application of gold leaf to electrodesiccated skin sites resulted in vascular activity and the production of unusual amounts of granulation tissue. This observation suggested the use of gold in ischemic lesions such as decubitus and arteriosclerotic ulcers of the skin, and resulted in rapid healing in ulcers previously unresponsive to other therapy. Beginning healing was evidenced as early as 2 days after the first application of the gold leaf.
Non-healing cutaneous ulcers means those which do not respond to usual active therapy. Usual active therapy means topical applications of antibiotic and proteolytic agents (including aloe vera). Granulation, as used herein, means tissue which includes blood vessels.
Complete healing was noted within four days (see table) in 6 lesions (four patients) and improvement was present in all treated sites. Complete epithelialization (and remnant discoloration) precluded histo-pathologic studies of these healed lesions. The deepest and widest ulcers of the leg of patient 1, previously surrounded by difiuse erythema, and presenting suppuration, maggot infestation and undermined borders have remained almost completely dry with apparent epithelialization of the borders. It is noteworthy that there has been no surrounding erythema and cellulitis since the third day of treatment. The least responsive lesion is one of two diabetic ulcers in patient 5 whose unhealed lesion appears 3 to have formed more granulation tissue but no epithelialization. A punch biopsy study revealed much granulation tissue in the margin of the lesions of patient 1.
Further studies have revealed curative and beneficial effects of the method when used for varicose ulcers, traumatic ulcers (including burn scars), sclerodermic ulcers, irradiation ulcers, decubitus ulcers, trophic ulcers, neurotic exoriations, erythema induratums, indurated lichenified lesions, and gangrene. In virtually all instances, except with non-painful diabetic ulcers, a marked reduction in pain occurred as soon as the gold leaf was applied. This treatment is also effective in prevention of ulceration, i.e., treatment of superficial bedsores. The treatment has not proved effective in the treatment of ulcers caused by sickle-cell anemia. It is not promising for treatment of normal previously non-pathological sites, such as superficial burns, since it is believed that an excessive amount of granulation tissue would result.
While the precise nature of the functions of the process are not known, it is believed that the application of gold leaf on to ulcers results in stimulation of vascular activity and the production of granulation tissue. The porosity of the gold leaf permits some evaporation of the moisture beneath it, it having been observed that if the leaf is covered by an occlusive substance or dressing, there is interference with healing. While, in some instances, the gold leaf can be applied Without initially swabbing of the site, it is preferred that the site first be swabbed with ethyl alcohol, not only to cleanse it, but also to establish the electrostatic differential which causes the leaf to adhere closely to the irregular surface of the ulcer with little or no further manipulation required.
In its broader aspect, the invention embraces a therapeutic device, i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin. The invention is not limited to the specific method or article, but is intended to cover all substitutions, modifications, and equivalents within the scope of the following claim.
I claim:
1. The method of stimulating epithelialization in a cutaneous region at and proximate to an avascular ulcer other than a cutaneous region fed by blood containing sickle cells by means of sterile porous gold leaf applied thereto which comprises, first establishing an electrostatic differential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying said sterile porous golf leaf in intimate engagement over said ulcer and the cutaneous surface immediately contiguous thereto, and maintaining said gold leaf so applied until epithelialization is stimulated and develops at the ulcer.
References Cited UNITED STATES PATENTS 3,326,213 6/1967 Gallagher 128156 ADELE M. EAGER, Primary Examiner.
US. Cl. X.R. 128156
US510161A 1965-11-24 1965-11-24 Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region Expired - Lifetime US3420233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51016165A 1965-11-24 1965-11-24

Publications (1)

Publication Number Publication Date
US3420233A true US3420233A (en) 1969-01-07

Family

ID=24029609

Family Applications (1)

Application Number Title Priority Date Filing Date
US510161A Expired - Lifetime US3420233A (en) 1965-11-24 1965-11-24 Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region

Country Status (1)

Country Link
US (1) US3420233A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2443836A1 (en) * 1978-12-13 1980-07-11 Perma Skin beauty treatment with substance active at body temp. - which is applied and covered with reflective aluminium foil
US20040049145A1 (en) * 1997-09-22 2004-03-11 Flick A. Bart Multilayer conductive appliance having wound healing and analgesic properties
US20050244484A1 (en) * 1997-09-22 2005-11-03 Flick A B Multilayer conductive appliance having wound healing and analgesic properties
US7005556B1 (en) 1995-09-05 2006-02-28 Argentum Medical Multilayer wound dressing
US20060264796A1 (en) * 1995-09-05 2006-11-23 Argentum Medical, Llc Medical device
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US8449514B2 (en) 1997-09-22 2013-05-28 Argentum Medical, Llc Conductive wound dressings and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326213A (en) * 1964-07-09 1967-06-20 John P Gallagher Therapeutic dressing material and method of using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326213A (en) * 1964-07-09 1967-06-20 John P Gallagher Therapeutic dressing material and method of using the same

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2443836A1 (en) * 1978-12-13 1980-07-11 Perma Skin beauty treatment with substance active at body temp. - which is applied and covered with reflective aluminium foil
US8118791B2 (en) 1995-09-05 2012-02-21 Argentum Medical, Llc Medical device
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US8293964B2 (en) 1995-09-05 2012-10-23 Argentum Medical, Llc Multilayer laminate wound dressing
US7005556B1 (en) 1995-09-05 2006-02-28 Argentum Medical Multilayer wound dressing
US20060264796A1 (en) * 1995-09-05 2006-11-23 Argentum Medical, Llc Medical device
US8283513B2 (en) 1995-09-05 2012-10-09 Argentum Medical, Llc Multilayer wound dressing
US20070179522A1 (en) * 1995-09-05 2007-08-02 Argentum Medical, Llc Multilayer wound dressing
US20080114279A1 (en) * 1995-09-05 2008-05-15 Argentum Medical, Llc Multilayer laminate wound dressing
US8449514B2 (en) 1997-09-22 2013-05-28 Argentum Medical, Llc Conductive wound dressings and methods of use
US6861570B1 (en) 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US7230153B2 (en) 1997-09-22 2007-06-12 Argentum International, Llc Multilayer conductive appliance having wound healing and analgesic properties
EP2316524A1 (en) 1997-09-22 2011-05-04 Argentum International, LLC Multilayer conductive appliance having wound healing and analgesic properties
US7989674B2 (en) 1997-09-22 2011-08-02 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US8093444B2 (en) 1997-09-22 2012-01-10 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US20040049145A1 (en) * 1997-09-22 2004-03-11 Flick A. Bart Multilayer conductive appliance having wound healing and analgesic properties
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US20050244484A1 (en) * 1997-09-22 2005-11-03 Flick A B Multilayer conductive appliance having wound healing and analgesic properties
US20080033506A1 (en) * 1997-09-22 2008-02-07 Argentum International, Llc Multilayer Conductive Appliance Having Wound Healing and Analgesic Properties
US8455710B2 (en) 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US7291762B2 (en) 1997-09-22 2007-11-06 Argentum International, Llc Multilayer conductive appliance having wound healing and analgesic properties

Similar Documents

Publication Publication Date Title
Lillis et al. Liposuction for treatment of axillary hyperhidrosis
Modaghegh et al. Use of phenytoin in healing of war and non‐war wounds: A pilot study of 25 cases
Ortonne A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers
US3420233A (en) Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region
US4330527A (en) Wound treatment agent
CN112933214A (en) Composition for promoting wound healing
Davis Surgical treatment of axillary hyperhidrosis
Brunsting et al. Cutaneous ulcers treated by the sulphydryl containing amino-acid cysteine
US3046196A (en) Therapeutic compositions
Lynch et al. The promotion of wound healing following chemosurgery (Mohs' technique) by dressings with a lotion of benzoyl peroxide
Glickman et al. Psoriatic angiogenic factor: evidence for its existence
RU2816783C1 (en) Method of treating an ingrown nail
RU2198702C1 (en) Method for preparing trophic ulcers to autodermatoplastic repair
Sher et al. Thorium X treatment of skin epithelioma, keratoses, and delayed radiation changes
LEVAN IMPROVED DERMAL ABRASION POSTOPERATIVE DRESSING
MONTGOMERY et al. Mosaic Type of Plantar Wart: Its Characteristics and Treatment
BERESTON et al. Treatment of undermining acne lesions by exteriorization
Blomgren et al. A Clinical Study of Trypure® or Varidase® on Minor Burns
UA144637U (en) COMPOSITION FOR LOCAL TREATMENT OF FUNGAL DISEASES OF SKIN AND NAILS
DUEMLING CUTANEOUS DISEASES IN THE SOUTH PACIFIC: OBSERVATIONS AMONG MILITARY FORCES
Samuels Gangrene of the heel
Veal et al. The preparation of superficial wounds for skin grafting by the local use of sulfanilamide and sulfanilamide-allantoin ointment
Feit The use of thorium X in treatment of pilonidal cyst: a preliminary report
Isaak Treatment of Cutaneous Diseases with Radon Ointment and Radium Pads: A Preliminary Report
Maplestone et al. Dermatitis Artefacta